Skip to content

Assessment of Accelerated Corneal Collagen Cross-Linking as an Adjuvant Therapy in Moderate to Severe Fungal Ulcers in comparison to conventional medical treatment

Assessment of Accelerated Corneal Collagen Cross-Linking as an Adjuvant Therapy in Moderate to Severe Fungal Keratitis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/033994
Enrollment
40
Registered
2021-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H160- Corneal ulcer Health Condition 2: H163- Interstitial and deep keratitis Health Condition 3: O- Medical and Surgical

Interventions

Intervention1: Accelerated corneal collagen cross with standard anti fungal I.e, natamycin 5% eye drops: Surgical Technique: After topical anaesthesia with proparacaine hydrochloride 0.5% eye drops .

Sponsors

Dr Rajendra Prasad Institute for Ophthalmic Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of smear positive fungal corneal ulcer and or demonstration of fungal hyphae in IVCM( In Vivo confocal microscopy ) 2 Size of ulcer more then 5 mm and stromal depth involvement more then 50 percent

Exclusion criteria

Exclusion criteria: 1 patients with corneal thickness less then 400 µm 2 Evidence of concomitant infection with herpes or bacterial 3 No perception of light in affected eye 4 Age less than 18 years or more than 70 years 5 Patients who were unable to complete follow up 6 Perforated corneal ulcer , corneal melting or perforation resulting to surgical intervention (therapeutic keratoplasty), endophthalmitis 7 Not willing to participate 8 Not able to come for follow-up

Design outcomes

Primary

MeasureTime frame
Percentage reduction in the infiltrate size after one and two weeks of the treatment in both armsTimepoint: 1 week ,2 week ,1 month ,3 month ,6 month

Secondary

MeasureTime frame
Time duration Taken took deduce the infiltrate size price 50% time taken for complete resolution of the ulcerTimepoint: 1 week ,2 week ,1 month ,3 month ,6 month

Countries

India

Contacts

Public ContactDr Himanshu Khandelwal

Dr R P Centre of ophthalmology

radhika_tan@yahoo.com91-11-26588919

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026